Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.625 -0.145 (-5.23%)

Streaming Delayed Price Updated: 10:44 AM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Iovance Biotherapeutics' TIL Therapy Achieves ORR Of 21.4% In Pre-Treated Lung Cancer Patients ↗

June 29, 2021

Iovance Biotherapeutics Inc (NASDAQ: IOVA) has announced clinical data for its tumor-infiltrating lymphocyte (TIL) therapy LN-145 in patients with metastatic non-...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 29, 2021

Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) shares moved upwards by 42.0% to $17.85 during Tuesday's pre-market session. The company's market cap stands at $2....

Via Benzinga

Should You Buy This Cathie Wood Biotech Stock? ↗

June 17, 2021

This biotech's fumble has caught the attention of a fund manager known for making innovative investments.

Via The Motley Fool

Best and Worst Russell 1000 Stocks So Far in June ↗

June 16, 2021

Right at the midpoint of June, Biogen has been the top-performing Russell 1,000 stock month to date.

Via Talk Markets

Why Iovance Biotherapeutics' Stock Is Trading Higher Today ↗

May 20, 2021

Iovance Biotherapeutics (NASDAQ:IOVA) shares are...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 10, 2021

Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares...

Via Benzinga

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗

June 07, 2021

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...

Via Benzinga

Iovance's Lifileucel Shows Meaningful Increase in Response Time with Primary Anti-PD-1 Resistance in Melanoma Trial ↗

June 07, 2021

Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced updated clinical data for lifileucel from Cohort 2 of C-144-01 clinical study in patients with advanced melanoma. Data...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 27, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

Most of ARKK Bouncing But Still Down Big ↗

May 25, 2021

After trading deep into oversold territory, the past two weeks have seen the ARK Innovation ETF erase some of the losses of the past few months.

Via Talk Markets

10 Biggest Price Target Changes For Monday ↗

May 24, 2021

Morgan Stanley raised Deere & Company (NYSE: DE) price target from $410 to $450. Deere shares rose 0.4% to $361.00 in pre-market trading. Oppenheimer cut Iovance...

Via Benzinga

Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA) ↗

May 24, 2021

Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherapeutics Inc (NASDAQ: IOVA) will benefit from its compelling tumor-...

Via Benzinga

Cathie Wood Loads Up Yet Another $51M In Coinbase As Shares Slump Amid Bitcoin-Led Crypto Carnage ↗

May 23, 2021

Cathie Wood-led Ark Investment Management on Friday snapped up another 223,181 shares, worth about $50.7 million, in Coinbase Global Inc

Via Benzinga

Here's Why Everyone's Talking About Iovance Biotherapeutics ↗

May 22, 2021

The CEO's unexplained departure has left investors scratching their heads.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 20, 2021

Gainers PDS Biotechnology (NASDAQ:PDSB) shares increased by 18.99% to $6.83 during Thursday's regular session. PDS Biotechnology's stock is trading at a volume of...

Via Benzinga

Iovance Shares Jump After Lifileucel Achieves 86% Response Rate In Melanoma Trial ↗

May 20, 2021

Yesterday the FDA asked Iovance Biotherapeutics Inc (NASDAQ: IOVA) for more data on the assays for lifileucel US application. Now the company announced ...

Via Benzinga

60 Biggest Movers From Yesterday ↗

May 21, 2021

Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

May 20, 2021

Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03. Precipio, Inc. (NASDAQ: PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2021 ↗

May 20, 2021

Upgrades According to Argus Research, the prior rating for Vontier Corp (NYSE:VNT) was changed from Hold to Buy. In the first quarter, Vontier earned $0.63. At the moment...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

May 20, 2021

Keybanc lowered the price target on Micron Technology, Inc. (NASDAQ: MU) from $137 to $115. Micron shares fell 0.1% to $79.88 in pre-market trading. Goldman Sachs cut SolarEdge...

Via Benzinga

50 Biggest Movers From Yesterday ↗

May 20, 2021

Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22. Reata...

Via Benzinga

The Law Offices of Frank R. Cruz Announces Investigation of Iovance Biotherapeutics, Inc. (IOVA) on Behalf of Investors

May 19, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

Additional Assay Data Holdup Delays Iovance's Lifileucel Filing Again, CEO Resigns; Shares Plunge ↗

May 19, 2021

In a brief statement, Iovance Biotherapeutics Inc (NASDAQ: IOVA) company divulged that the FDA wants to see more data on the assays used to ensure each batch...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 1%; Iovance Biotherapeutics Shares Plunge ↗

May 19, 2021

Toward the end of trading Wednesday, the Dow traded down 1.08% to 33,693.98 while the NASDAQ fell 0.66% to 13,215.41. The S&P also fell, dropping 0.94% to 4,088.99. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 19, 2021

Gainers Lianluo Smart (NASDAQ:LLIT) stock rose 35.13% to $10.0 during Wednesday's regular session. Lianluo Smart's stock is trading at a volume of 4.6 million...

Via Benzinga

Mid-Day Market Update: Crude Oil Down 5%; Reata Pharmaceuticals Shares Jump ↗

May 19, 2021

Midway through trading Wednesday, the Dow traded down 1.32% to 33,610.27 while the NASDAQ fell 0.89% to 13,184.68. The S&P also fell, dropping 1.20% to 4,078.44. The U.S. has...

Via Benzinga

Topics Stocks

Why Iovance Biotherapeutics Stock Is Crashing Today ↗

May 19, 2021

The company is delaying the FDA approval filing for cell therapy lifileucel.

Via The Motley Fool

35 Stocks Moving In Wednesday's Mid-Day Session ↗

May 19, 2021

Gainers Advaxis, Inc. (NASDAQ: ADXS) shares jumped 43.1% to $0.6943 after jumping over 14% on Tuesday. MoSys, Inc. (NASDAQ: MOSY) shares gained 32% to $5.00. Reata...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Target Profit Beats Estimates ↗

May 19, 2021

Following the market opening Wednesday, the Dow traded down 1.47% to 33,559.29 while the NASDAQ fell 1.29% to 13,131.99. The S&P also fell, dropping 1.42% to 4,069.40. The U.S...

Via Benzinga

Topics Stocks

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.